0H68.L
Get informed when a big investor buys or sells
+ FollowOvervalued by 38.8% based on the discounted cash flow analysis.
| Market cap | $60.27 Billion |
|---|---|
| Enterprise Value | $55.74 Billion |
| Dividend Yield | $2.41 (2.10%) |
| Earnings per Share | $6.84 |
| Beta | 0.6 |
| Outstanding Shares | 504,123,000 |
| P/E Ratio | 12.29 |
|---|---|
| PEG | 32.57 |
| Price to Sales | 3.33 |
| Price to Book Ratio | 1.14 |
| Enterprise Value to Revenue | 3.09 |
| Enterprise Value to EBIT | 19.31 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.05 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Aflac Incorporated, operating through its various subsidiary entities, primarily delivers supplementary health and life insurance solutions. Its business is structured into two main operating divisions: Aflac Japan and Aflac U.S. Within ...